Eric A. Hughes - 01 Aug 2022 Form 3 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role: Executive Vice President, Global R&D and Chief Medical Officer
Signature: /s/ Dov Bergwerk as attorney-in-fact for Eric A. Hughes
Issuer symbol: TEVA
Transactions as of: 01 Aug 2022
Net transactions value: $0
Form type: 3
Filing time: 03 Aug 2022, 07:10:42 UTC
Next filing: 07 Mar 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Executive Vice President, Global R&D and Chief Medical Officer